A Case of JAK2 p.V617F Positive Myeloproliferative Disorder With a Concomitant BCR-ABL1-Positive Clone

被引:0
|
作者
Wake, Laura [1 ]
Cushman-Vokoun, Allison [1 ]
机构
[1] Univ Nebraska Med Ctr, Omaha, NE USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
189
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Concomitant BCR ABL Translocation and JAK2 V617F Mutation in Myeloproliferative Disorders
    Hummel, J. M.
    Sanks, J.
    Chiselite, M.
    Smith, L. B.
    Johnson, K. Elenitoba
    Lim, M. S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 869 - 869
  • [2] Concomitant BCR-ABL and JAK2 V617F in a Patient with Myeloproliferative Neoplasm: A Case Report
    Suzana, Alia A.
    Azlin, I
    Hafiza, A.
    Rafeah, Nor T.
    Mariam, Siti T.
    Norunaluwar, J.
    Salwati, S.
    Azma, R. Z.
    [J]. MEDICINE AND HEALTH, 2023, 18 (01): : 233 - 240
  • [3] BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance
    Martin-Cabrera, Pedro
    Haferlach, Claudia
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Torsten
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (01) : 135 - 139
  • [4] Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib
    Luque Paz, Damien
    Ianotto, Jean-Christophe
    Chauveau, Aurelie
    Guibourg, Briac
    Lecucq, Lydie
    Lippert, Eric
    Ugo, Valerie
    [J]. ANNALS OF HEMATOLOGY, 2016, 95 (02) : 349 - 350
  • [5] Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib
    Damien Luque Paz
    Jean-Christophe Ianotto
    Aurélie Chauveau
    Briac Guibourg
    Lydie Lecucq
    Eric Lippert
    Valérie Ugo
    [J]. Annals of Hematology, 2016, 95 : 349 - 350
  • [6] Rare examples of Philadelphia positive CML with concomitant BCR-ABL1 translocation and JAK2 V617F mutation
    Akiki, S.
    Rose, S.
    Bryon, J.
    Jeffries, S.
    Murray, J.
    Raghavan, M.
    Griffiths, M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 77 - 77
  • [7] Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients
    Lange, Thoralf
    Edelmann, Anja
    Siebolts, Uwe
    Nehring, Claudia
    Jaeckel, Nadja
    Cross, Michael
    Jacqueline, Maier
    Niederwieser, Dietger
    Wickenhauser, Claudia
    [J]. BLOOD, 2010, 116 (21) : 1421 - 1421
  • [8] MOLECULAR CHARACTERIZATION OF MYELOPROLIFERATIVE NEOPLASMS WITH CONCOMITANT BCR-ABL1 AND JAK2 V617F OR CALRETICULIN MUTATIONS
    Bodor, C.
    Kiraly, P.
    Krahling, T.
    Gango, A.
    Marosvari, D.
    Masszi, T.
    Fekete, S.
    Ujj, G.
    Egyed, M.
    Farkas, P.
    Csomor, J.
    Kajtar, B.
    Bors, A.
    Tordai, A.
    Andrikovics, H.
    [J]. HAEMATOLOGICA, 2016, 101 : 551 - 551
  • [9] Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib
    Zhou, A.
    Knoche, E. M.
    Engle, E. K.
    Fisher, D. A. C.
    Oh, S. T.
    [J]. BLOOD CANCER JOURNAL, 2015, 5 : e351 - e351
  • [10] Concomitant JAK2 V617F-Positive Polycythemia Vera and BCR-ABL-Positive Chronic Myelogenous Leukemia Treated with Ruxolitinib and Dasatinib
    Knoche, Eric M.
    Fisher, Daniel A. C.
    Rippberger, Gregory
    He, Li
    Moore, Deborah M.
    Klein, Jonathan L.
    Oh, Stephen T.
    [J]. BLOOD, 2012, 120 (21)